Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Fibrosis × Lamivudine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Failure, Acute 1 Hepatitis B 1 Fibrosis 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 sofosbuvir-velpatasvir drug combination 1 navitoclax 1 hepatitis B hyperimmune globulin 1 adefovir dipivoxil 1 Sorafenib 1 Simvastatin 1 Lamivudine 1 High-Energy Shock Waves 1 Erlotinib Hydrochloride 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡